このエントリーをはてなブックマークに追加
ID 31835
JaLCDOI
フルテキストURL
fulltext.pdf 3.07 MB
著者
Takayama, Fusako Department of Clinical Pharmaceutical Science, Okayama University, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Nakamoto, Kazuo Department of Clinical Pharmaceutical Science, Okayama University, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Kawasaki, Hiromu Department of Clinical Pharmaceutical Science, Okayama University, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Kaken ID publons
Mankura, Mitsumasa Anti-Aging Food Sciences, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Egashira, Toru Anti-Aging Food Sciences, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Ueki, Keiji Hiruzen Winery Co., Ltd.
Hasegawa, Azusa Department of Clinical Pharmaceutical Science, Okayama University, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Okada, Shigeru Anti-Aging Food Sciences, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Mori, Akitane Anti-Aging Food Sciences, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
抄録

Vitis coignetiae Pulliat (Yamabudo) is used as a health juice and wine based on the abundant polyphenols and anthocyanins in its fruit. However, it is not known whether the leaves of this plant confer similar benefits. This study investigated the hepatoprotective effects of aqueous extracts from Vitis coignetiae Pulliat leaves (VCPL) in an animal model of nonalcoholic steatohepatitis (NASH). Rats were fed a choline-deficient high-fat diet for four weeks to generate fatty livers. NASH was induced by oxidative stress loading. Ten weeks later, blood and liver samples were collected from anesthetized animals and assessed biochemically, histologically, and histochemically to determine the extent of oxidative stress injury and the overall effects of VCPL. Six-week VCPL extract supplementation reduced serum levels of liver enzymes, decreased CYP2E1 induction, increased plasma antioxidant activities and delayed the progression of liver fibrosis. The findings suggested that VCPL has strong radical-scavenging activity and may be beneficial in preventing NASH progression.

キーワード
Yamabudo
nonalcoholic steatohepatitis
antioxidant
hepatoprotection
Amo Type
Original Article
出版物タイトル
Acta Medica Okayama
発行日
2009-04
63巻
2号
出版者
Okayama University Medical School
開始ページ
105
終了ページ
111
ISSN
0386-300X
NCID
AA00508441
資料タイプ
学術雑誌論文
言語
英語
論文のバージョン
publisher
査読
有り
PubMed ID
Web of Science KeyUT